Related Experiment Videos
Self-treatment of hypoglycemia while driving
D J Cox1, L A Gonder-Frederick, B P Kovatchev
1University of Virginia Health System, Behavioral Medicine Center, Box 800-223, Charlottesville, VA 22908, USA. djc4f@virginia.edu
Diabetes Research and Clinical Practice
|September 5, 2001
Summary
Drivers with Type 1 Diabetes Mellitus (T1DM) who recognized hypoglycemia symptoms and self-treated while driving performed better. Vigilance for symptoms like trembling is crucial for safe driving with T1DM.
Area of Science:
- Neuroscience
- Endocrinology
- Driving Safety
Background:
- Diabetic hypoglycemia impairs driving ability due to neuroglycopenia.
- Patient detection and self-correction of hypoglycemia-induced driving impairments are not fully understood.
Purpose of the Study:
- To compare physiological and psychological factors in Type 1 Diabetes Mellitus (T1DM) drivers who self-treated versus those who did not during experimental hypoglycemia and driving.
- To identify predictors of self-treatment in T1DM drivers experiencing hypoglycemia.
Main Methods:
- 38 T1DM drivers completed simulated driving tests under euglycemic and progressive hypoglycemic conditions.
- Continuous monitoring of driving performance, EEG, and self-treatment behavior.
- Frequent measurements of blood glucose, epinephrine, and perceived symptoms/driving ability.
Main Results:
- Self-treating drivers detected more neurogenic and neuroglycopenic symptoms.
- Self-treaters exhibited less EEG-defined neuroglycopenia during hypoglycemia.
- Perceived need to self-treat and EEG parameters accurately classified 88% of drivers based on treatment behavior.
- Self-treating drivers demonstrated greater awareness of hypoglycemia and driving risks in a field study.
Conclusions:
- A critical window exists between symptom detection and neuroglycopenia onset, impacting self-treatment efficacy.
- T1DM drivers must remain vigilant for hypoglycemia symptoms (e.g., trembling, visual issues) and self-treat promptly while driving.